Epidermal Growth Factor Receptor (EGFR) gene mutation testing is a critical first step in the personalised treatment of patients with non-squamous non-small cell lung cancer (NSCLC). The gene discussed is EGFR; the disease is non-small cell squamous lung carcinoma.